BriaCell Therapeutics Newsroom

Promising Phase 2 Results and Safety Profile Justify Buy Rating for BriaCell Therapeutics

TipRanksDec 12 19:30

BriaCell Therapeutics Analyst Ratings

BenzingaDec 3 20:41

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

BenzingaDec 3 20:41

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target

BenzingaOct 3 19:02

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target

BenzingaSep 12 01:05

BriaCell Therapeutics Analyst Ratings

BenzingaJun 4 18:55

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target

BenzingaJun 4 18:55

BriaCell Therapeutics Analyst Ratings

BenzingaMay 24 19:25

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target

BenzingaMay 24 19:25

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target

BenzingaDec 29, 2023 00:30

BriaCell Therapeutics Analyst Ratings

BenzingaDec 29, 2023 00:27

BriaCell Therapeutics (BCT) Gets a Buy Rating From H.C. Wainwright

TipRanksOct 27, 2023 18:21

HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Lowers Price Target to $20

BenzingaOct 4, 2023 00:03

BriaCell Therapeutics Analyst Ratings

BenzingaOct 4, 2023 00:01

BriaCell Therapeutics (BCT) Initiated With a Buy at H.C. Wainwright

TipRanksOct 3, 2023 23:30

BriaCell Therapeutics (BCT) Initiated With a Buy at H.C. Wainwright

TipRanksSep 9, 2023 00:10

BriaCell Therapeutics (BCT) Gets a Buy Rating From H.C. Wainwright

TipRanksJun 28, 2023 18:20

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target

BenzingaJun 28, 2023 18:12

BriaCell Therapeutics Analyst Ratings

BenzingaFeb 24, 2023 19:50

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target

BenzingaFeb 24, 2023 19:30